MedicaidPrior AuthMedium impact
KMAP BULLETIN: Pharmaceutical Prior Authorization Updates
Kansas Medicaid (KanCare)·KS · Endocrinology, Ophthalmology, Allergy & Immunology +2 more·Provider Bulletin
Effective date
Dec 1, 2024
We identified it
Jun 21, 2026
Summary
Effective December 1, 2024, five medications (Neffy epinephrine, Omvoh, Zituvimet XR, Undecatrex testosterone, and iDose TR travoprost implant) will become non-preferred on the Kansas Medicaid Preferred Drug List and require prior authorization. This affects Kansas providers prescribing these medications to Medicaid patients.
Action Required
By December 1, 2024: Providers must obtain PDL Prior Authorization before prescribing Neffy (epinephrine), Omvoh (mirikizumab-mrkz), Zituvimet XR (sitagliptin/metformin XR), Undecatrex (testosterone undecanoate), and iDose TR (travoprost implant) for Kansas Medicaid patients. Update EMR systems to flag these medications as requiring prior auth. Monitor the KanCare Open Claims Resolution Log for MCO-specific implementation dates as timing may vary by managed care organization.